Menü Kapat

Orjinal Article

Efficacy of High Dose Chemotherapy in Adult Patients with Relapsed or Refractory Ewing Sarcoma

Receiving Date: 04 May 2022

Accept Date: 22 July 2022

Available Online: 25.08.2022

doi: 10.5455/medscience.2022.05.106

Medicine Science 2022;11(3): 1238-41

Conflict of interests: The authors declare that there is no conflict of interest in the study.
Financial Disclosure: The authors declare that they have received no financial support for the study.
Ethical approval: The study was approved by the local ethics committee of SBU Gülhane Training and Research Hospital clinical trials (ethics committee 2021/96).

Figure 1. Median progression-free survival curve after HDC

 1,780 total views,  13 views today

Aykan MB, Keskin GS, Ornek E, et al. Efficacy of High Dose Chemotherapy in Adult Patients with Relapsed or Refractory Ewing Sarcoma. Med Science. 2022;11(3):1238-41.

⇓ PlumX Meter

Corresponding Author: Musa Baris Aykan, Ankara Gülhane Faculty of Medicine, Department of Oncology, Ankara Turkey.
E-mail: musabarisaykan@gmail.com

Posted in Vol: 11 Issue: 3 Year: 2022 September pp: 944-1394

Related Posts

%d blogcu bunu beğendi: